Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chondrosarcoma × regorafenib × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 35 Carcinoma, Hepatocellular 14 Rectal Neoplasms 8 Neoplasm Metastasis 8 Colonic Neoplasms 7 Gastrointestinal Stromal Tumors 6 Ovarian Neoplasms 5 Sarcoma 4 Melanoma 4 Osteosarcoma 3 Glioblastoma 3 Cholangiocarcinoma 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Liver Neoplasms 2 Gallbladder Neoplasms 2 Fatigue 2 Colorectal Cancer Metastatic 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Thymoma 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma 1 Noonan Syndrome 6 1 Neoplasms 1 Multiple Myeloma 1

Interventions

Ifosfamide 3 Filgrastim 3 Peripheral Blood Stem Cell Transplantation 2 Etoposide 2 Carboplatin 2 spartalizumab 1 regorafenib 1 perifosine 1 pegfilgrastim 1 pazopanib 1 ivosidenib 1 etoposide phosphate 1 enasidenib 1 drozitumab 1 angiotensin I (1-7) 1 alanosine 1 abemaciclib 1 Vincristine 1 Trabectedin 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Proton Therapy 1 Pharmacogenomic Testing 1 Pemetrexed 1 Nivolumab 1 Microarray Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02389244 2025-09-16

REGOBONE

UNICANCER

Phase 2 Active not recruiting

Chondroma, Chondrosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡